Joseph Edelman – SYRE history
- Issuer:
- SPYRE THERAPEUTICS INC
- Quarters tracked:
- 11 (Q3 2023 → Q1 2026)
- Current shares:
- 3,783,225
- Current value:
- $190.83M
- Peak shares:
- 3,783,225 (Q1 2026)
- Overall change:
- +4564%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 3,783,225 | $190.83M | $50.44 | +714,000 | +23% |
| Q4 2025 | 3,069,225 | $100.55M | $32.76 | +1,839,780 | +150% |
| Q3 2025 | 1,229,445 | $20.61M | $16.76 | -300,000 | -20% |
| Q2 2025 | 1,529,445 | $22.90M | $14.97 | -783,827 | -34% |
| Q1 2025 | 2,313,272 | $37.33M | $16.14 | -261,451 | -10% |
| Q4 2024 | 2,574,723 | $59.94M | $23.28 | -297,824 | -10% |
| Q3 2024 | 2,872,547 | $84.48M | $29.41 | -158,471 | -5% |
| Q2 2024 | 3,031,018 | $71.26M | $23.51 | +474,339 | +19% |
| Q1 2024 | 2,556,679 | $96.97M | $37.93 | -50,000 | -2% |
| Q4 2023 | 2,606,679 | $56.10M | $21.52 | +2,525,563 | +3114% |
| Q3 2023 | 81,116 | $994K | $12.25 | — | NEW |